• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.73% Nasdaq Down0.96%

    More On LZAGY

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Lonza Group Ltd (LZAGY)

    -Other OTC
    13.93 Down 0.10(0.71%) Jul 27, 3:57PM EDT
    |Pre-Market : NaN
    Add to Portfolio
    ProfileGet Profile for:
    Lonza Group Ltd
    Muenchensteinerstrasse 38
    Basel, 4002
    Switzerland - Map
    Phone: 41 61 316 81 11
    Fax: 41 61 316 91 11
    Website: http://www.lonza.com

    Details 
    Index Membership:N/A
    Sector:N/A
    Industry:N/A
    Full Time Employees:9,809

    Business Summary 

    Lonza Group Ltd. supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Specialty Ingredients and Pharma&Biotech. The Specialty Ingredients segment offers consumer care products comprising actives for antidandruff shampoos, and natural and organic cosmetic ingredients; vitamin B compounds; and microbial control solutions, including disinfectants and sanitizers that protect from dangerous and unwanted microbes. This segment also provides custom agricultural manufacturing services to enhance crop yields and food quality; industrial Solutions, including preservatives and biocide blends; products and services that enhance the quality of wood; and sanitizers and other treatment chemicals for pools, spas, water parks, as well as in the treatment of surface waters for drinking, agriculture, irrigation, food processing, and industrial applications. The Pharma&Biotech segment develops and manufactures active pharmaceutical ingredients (APIs) for drug companies; microbial parenteral API, including antibody fragments, vaccines, cytokines, plasmid DNA, fusion proteins, and PEGylated products; and chemical custom services, such as chemically derived active ingredients, peptide syntheses, antibody drug conjugates, cytotoxic, and small organic molecules. It also offers cell culture, transfection, and molecular biology tools for life-science research; media used in the production of therapeutics; endotoxin detection assays; and products and services targeting cardiovascular, respiratory, neurological, metabolic, cancer, and other disease research areas. This segment serves customers in academic and government institutions, and in biotech and pharmaceutical organizations. Lonza Group Ltd. was founded in 1897 and is headquartered in Basel, Switzerland.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Lonza Group Ltd

    Key Executives 
     PayExercised
    Mr. Richard Ridinger , 57
    Chief Exec. Officer
    1.65MN/A
    Dr. Toralf A. Haag , 49
    Chief Financial Officer
    N/AN/A
    Mr. Dirk Oehlers ,
    Head of Investor Relations
    N/AN/A
    Mr. Marc Funk , 55
    Chief Legal Officer, Chief Operating Officer of Pharma & Biotech Market Segment and Sec.
    N/AN/A
    Mr. Dominik Werner ,
    Head of Corp. Communications
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.